---
title: "Inside the Tricog CardioCheck algorithm"
canonical: https://tricogcardiocheck.com/resources/inside-the-tricog-cardiocheck-algorithm.html
author: Prateek Golecha
publisher: Tricog Health
date_published: 2026-06-19
reading_time: 8 min
doc_type: article
topics: algorithm architecture, multi-scale ECG analysis, risk tiers
entity: Tricog CardioCheck
last_updated: 2026-09-10
---

# Inside the Tricog CardioCheck algorithm

**Quick answer:** AI ECG screening uses a trained algorithm to read an ECG and return a risk category in seconds, with no specialist in the loop. Tricog CardioCheck applies it to a 30-second single-lead ECG, reading beat shape, ST-segment and T-wave change, and rhythm simultaneously, then classifying every trace as Low, Moderate or High risk.

### What is AI ECG screening?

AI ECG screening is the use of a deep learning model to interpret an ECG trace at the point of capture and assign it a clinical priority. The doctor still decides. The algorithm decides who the doctor sees first.

That distinction matters more in India than almost anywhere else. A 2026 *European Heart Journal* review puts the country at roughly 5,500 cardiologists as of 2021 — about one per 30,000 people — while cardiovascular disease accounted for 29.5% of all Indian deaths in 2021, or 2.87 million people. The WHO attributes 45% of deaths in the 40–69 age group to CVD. India does not have an ECG shortage. It has a shortage of people qualified to read one quickly.

### Why do most single-lead ECG algorithms only detect rhythm?

Most single-lead algorithms detect rhythm because they were designed as rhythm monitors, not screening tools. They report heart rate, R-R interval variability and sometimes atrial fibrillation, and stop there. The result is a category-wide assumption that single-lead ECG is a consumer rhythm gadget, useful for palpitations and nothing else.

Tricog CardioCheck (TCC) is built on the opposite premise: a clean 30-second single-lead trace also carries structural and ischaemic information, provided the model reads it at more than one resolution.

### How does the algorithm read one ECG at three scales?

TCC reads every trace at three temporal resolutions at once and fuses the three feature sets before it classifies anything. The design mirrors how a cardiologist works a strip: sweep for rhythm, interrogate individual beats, then judge the whole.

**Fine scale — beat-level morphology.** QRS complex morphology, P-wave presence and shape, localised conduction anomalies. This is where the earliest silent indicators appear, in patients whose vitals look unremarkable.

**Medium scale — ischaemic markers.** ST-segment deviation and T-wave abnormality: the band between a subtle waveform shift and overt disease, and the band a rhythm-only algorithm is structurally blind to.

**Coarse scale — rhythm and trend.** Rhythm consistency and long-range trend across the full 30 seconds, catching irregularity that no single beat-level window would reveal.

Because the three scales run in parallel rather than in sequence, a finding that is ambiguous at one resolution can be resolved by context from another. A borderline ST change is read against the rhythm it sits inside, not in isolation.

### Why is a multi-scale model more accurate than a single-scale one?

A single-resolution model forces a trade-off that cannot be won. Tune it for fine waveform detail and it over-reads motion artefact, flooding the clinic with false alarms. Tune it for rhythm and it misses ST-segment and T-wave change, which is where much of ischaemia declares itself. Most products land in the middle and are mediocre at both.

Reading all three horizons simultaneously removes the trade-off rather than splitting it. That is the entire architectural argument, and it is what allows a single lead to function as a screening instrument instead of a rhythm alert.

### What it detects at each risk level

High risk — time-critical findings including myocardial infarction and atrial fibrillation, where the Golden Hour is the binding constraint.

Moderate risk — ventricular hypertrophy and ischaemia. Not immediately life-threatening, but requiring focused evaluation in days, not weeks.

Low risk — normal sinus rhythm and benign variants, allowing stable patients to be routed out of critical pathways.

The low-risk category is the one buyers underrate. Screening tools get judged on what they catch, but in a clinic running forty patients through one physician, a confident clearance is worth as much as a flag.

### How accurate is it?

These are the figures Tricog reports on held-out benchmark data.

AUROC 0.909 [95% CI 0.905–0.913] overall discrimination.

85.9% sensitivity [84.6–87.0] at 92.2% specificity [91.6–92.9] for high-risk detection.

90.2% sensitivity [89.2–91.2] for low-risk classification.

Trained on millions of ECGs, with class imbalance corrected explicitly.

That last line carries real weight. Life-threatening findings are rare in any real dataset, so a naively trained model becomes excellent at recognising normal and quietly unreliable at recognising emergencies. Correcting class imbalance during training is also what keeps performance stable across demographic groups, because rare cases stop being treated as noise.

### Can it override a cardiologist?

No. TCC is additive by design: it can escalate a patient's priority and can never downgrade it or override a clinical decision.

The commercial consequence is worth saying plainly. Because the model only pushes patients up the queue, deploying it cannot make triage worse than current practice. The floor is no change. Everything above the floor is upside — which is a rare risk profile for clinical AI.

### Where it fits in the workflow

At the front of it. The ECG is captured alongside vitals, the risk category appears in about ten seconds, and the queue reorders before the first patient is called in. No upload-and-wait, no specialist backlog, and no cardiologist time spent confirming normal sinus rhythm.

That is what TCC actually sells: not an ECG reader, but a triage layer that runs where the patient already is.

### FAQ

**Is a single-lead ECG accurate enough for cardiac risk screening?**
For screening and triage, yes, provided the algorithm reads more than rhythm. TCC reports AUROC 0.909 and 85.9% sensitivity for high-risk findings on a 30-second single-lead trace. It is not a substitute for a 12-lead ECG or a diagnosis.

**How long does an AI ECG screening result take?**
About ten seconds after a 30-second capture, delivered at the point of care rather than after a specialist read.

**Can AI ECG screening clear a patient as low risk?**
It classifies low-risk traces with 90.2% sensitivity, which is what makes it safe for routing stable patients out of critical pathways. A clinician can escalate a low-risk result at any time; the model cannot de-escalate anyone.

## Sources

1. Judith Ozkan, "India: challenges and opportunities for cardiologists," *European Heart Journal*, Vol. 47, Issue 13, April 2026 — https://academic.oup.com/eurheartj/article/47/13/1505/8417274
2. World Health Organization India, Cardiovascular diseases — https://www.who.int/india/health-topics/cardiovascular-diseases

## Related

- [All resources](../resources.md) · [Home](../index.md) · [Glossary](../ai/glossary/index.md) · [Research](../ai/research/index.md)
